![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_7c1f47f3c7bae38fb065c983ece631c1.svg) | Vandetanib | IC50 | 25.0 [1], 400.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_9c062cd6c7c1362062730d56f1c53648.svg) | N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[2-(triazol-1-yl)ethoxy]quinazolin-4-amine | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_a47a95df2c07aaf70d5a2f3dce77d01e.svg) | 6-(4-Methoxyphenyl)-3-(3-thienyl)-pyrazolo(1,5-a)pyrimidine | IC50 | 387.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f804066652b7b93c95ab28d40b43d40c.svg) | Pyrazolo[1,5-a]pyrimidine 1a | IC50 | 622.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_c0a25f544489a2780cecab52d7329459.svg) | Pyrazolo[1,5-a]pyrimidine 2c | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_e2f99194617c96946324b426e112d809.svg) | Erlotinib | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_9d111ca31c6b5557bbe95cc7cad92c76.svg) | Vatalanib | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_a59db47f5f7aa063c6007dcf79b51cfe.svg) | PD173074 | IC50 | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_be3228e8cfdb7d29d853ed1201fa8054.svg) | Raf265(chir-265) | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_8030213d9f30efd3da30350a03e56f0d.svg) | PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 3100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6925afc0497f067aee8668b4ed241d61.svg) | N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_70fa82b2684497746cdcfb90512df438.svg) | N-(4-Chlorophenylsulfonyl)benzamide | IC50 | 22000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_27155136dbc077658c8857b4cc311fec.svg) | 4-[2-[4-(3-Phenylpyrazolo[1,5-a]pyrimidin-6-yl)phenoxy]ethyl]morpholine | IC50 | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_fcf6f06908c614089523391d5524167f.svg) | 2-Oxazolamine, N,5-diphenyl- | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_31aed535edd9b2a22f8b66768719ae40.svg) | N-[2,4-Dichlorobenzoyl]phenylsulfonamide | IC50 | 530.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_7505f3134f1fe4be873c0e48936d8121.svg) | 2,4-Dichloro-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_82a13a633b8f65c389f3bdb54bcfdedb.svg) | 4-[2-(3-Tert-butylanilino)-1-methylbenzimidazol-5-yl]oxy-N-methylpyridine-2-carboxamide | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_8af081cfd985a9035dd01393c2589906.svg) | N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine | IC50 | 370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_3a1888c73237fa75c62c6753d17533df.svg) | N-(3-Methylphenyl)-5-phenyl-1,3-oxazol-2-amine | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6e5554821398d24b3a8f892eede06053.svg) | 4-[(5-Phenyl-1,3-oxazol-2-yl)amino]benzenesulfonamide | IC50 | 4660.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6e72c5bb7ca88b49260ed870f238c7e4.svg) | N-(3,5-Dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine | IC50 | 1690.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_efbab9428fe755abc51e943a9227f3b4.svg) | 5-Phenyl-N-(3,4,5-trimethoxyphenyl)-1,3-oxazol-2-amine | IC50 | 420.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_eb477e2b064ccdf3c5e7c96802a22c3c.svg) | 2-Anilino-5-aryloxazole 20 | IC50 | 1310.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_fcb22303d898dce13d207f1cd6c52351.svg) | 2-Anilino-5-aryloxazole 24 | IC50 | 7600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6634ee6f8862780cfeaf01b39a491de3.svg) | 2-Anilino-5-aryloxazole 27 | IC50 | 1650.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_50071d085add6f9dfe064cfe44e6ab58.svg) | 2-Anilino-5-aryloxazole 28 | IC50 | 350.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_fd3cd325c6e00eb5a11fb2d22d9a2ad7.svg) | 1-[3-(2-{[5-(Ethylsulfonyl)-2-methoxyphenyl]amino}-1,3-oxazol-5-yl)phenyl]ethanone | IC50 | 13900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_43a698e6f513b14e26019aca85616526.svg) | 2-Anilino-5-aryloxazole 44 | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_edc84196e7f0496a1c21e674ea92f53d.svg) | Unii-8FX9DP2Y1W | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_48cbc600be7e69bce913ec1d49cf9932.svg) | 2,4-Difluoro-N-methoxy-5-[[6-(5-methyl-1,3,4-oxadiazol-2-yl)-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]benzamide | IC50 | 7.6 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f441851b7d3335f928c0771fb5465528.svg) | N-(4-Chloro-2-fluorophenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_899d631a52defa84d00d786eadc5ecb0.svg) | Pyrazolo[1,5-a]pyrimidine 4e | IC50 | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_30ed6f9f9f64fdc67231237d542155b2.svg) | 4-[2-[4-(3-Pyridin-4-ylpyrazolo[1,5-a]pyrimidin-6-yl)phenoxy]ethyl]morpholine | IC50 | 31.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_5b10441bbfcd2a7880fba7127c6144c0.svg) | 3-[[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f506567356776a9799617a885fd1c738.svg) | 5-[[6-[5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]-2,4-difluoro-N-methoxybenzamide | IC50 | 17.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_ed72db15b7249db1d15a03ab1ab2ff6c.svg) | 2,4-Difluoro-N-methoxy-5-[[6-(5-methyl-1,3-oxazol-2-yl)-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]benzamide | IC50 | 1.1 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_a957dfdf77ebbe7085e4dacc9614fe5c.svg) | 2,4-Difluoro-N-methoxy-5-[[6-[5-(methylsulfonylmethyl)-1,3,4-oxadiazol-2-yl]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]benzamide | IC50 | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_c716606beadd8dd6472d027c5de91b70.svg) | 2,4-Dichloro-N-(3,4-dichlorophenyl)sulfonylbenzamide | IC50 | 460.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_13f732ec673914c1007fb88b74dd16e2.svg) | (3-Chloro-4-fluoro-phenyl)-(5-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-amine | IC50 | 2500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f567ab680eea9ec0c81b6ebf488c9cd1.svg) | 5-[[6-[5-[Difluoro(methylsulfonyl)methyl]-1,3,4-oxadiazol-2-yl]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]-2,4-difluoro-N-methoxybenzamide | IC50 | 27.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_4994ce25fd2d766c8a82f54ae8e6690a.svg) | 1-(3-Cyanophenyl)-3-(4,6,8,9-tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)urea | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_2644af2cd4fbf4274ba8b7827e25ad4a.svg) | 1-(4-Fluorophenyl)-3-(4,6,8,9-tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)urea | IC50 | 631.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_231f07418aa02817c9b1976439349af8.svg) | 1-(4,6,8,9-Tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)-3-[4-(trifluoromethyl)phenyl]urea | IC50 | 3980.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_4fb12dd1e29bea68fdac93941d3a7f6b.svg) | 1-(4,6,8,9-Tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 251.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_fdcc21875d688c6fdc8a314c9c5a31c0.svg) | 1-(3-Nitrophenyl)-3-(4,6,8,9-tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)urea | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_c2421be64316f57778172630b98df9f2.svg) | 1-(4-Bromophenyl)-3-(4,6,8,9-tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,7,10,12-hexaen-3-yl)urea | IC50 | 3980.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_46b256ec54d5cc122ecfb7d1e2fbe009.svg) | Vandetanib hydrochloride | IC50 | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_4638e896a0e6c1b03c6bb448ac48aa90.svg) | 1,6-Naphthyridine deriv. 20 | IC50 | 37.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_3e3ec3f6b15bbe00f869d3141f5a04a2.svg) | Anilinoquinazoline deriv. 21 | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_63216cb9f6b3fffcaebccb81fc8effbe.svg) | Anilinoquinazoline deriv. 22 | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f8eae3bc9bf99cdf9a370bf2e202458c.svg) | Anilinoquinazoline deriv. 28 | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_1fe48754accc63ea44da062dbfab103f.svg) | 3-(5-Thien-3-ylpyridin-3-yl)-1Hindole 3f | IC50 | 328.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_5c4477e6ea540c50f4a78b1108b30576.svg) | 2,4-Disubstituted Pyrimidine 2d | IC50 | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_98344ec8b5ef130fa40ee971d2afb516.svg) | Pyrazolo[1,5-a]pyrimidine 4a | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_08e7d659d7dd61847f49a9f87f09387c.svg) | Pyrazolo[1,5-a]pyrimidine 4g | IC50 | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_89a9df3144cd0ad5485d3fb574d7d864.svg) | N-[4-[2-(3-Tert-butylanilino)-1-methylbenzimidazol-5-yl]oxypyridin-2-yl]acetamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_e119472c4d9925e699302b132ea47451.svg) | 2-Methyl-5-(pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol | IC50 | 360000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_75abbe4b7e9b789b4cd3657fc0526e7a.svg) | 4-Bromo-2-chloro-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_cb1d260aa84a15fd1d2a734f42bbb508.svg) | 2-Methyl-5-(6-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol | IC50 | 213000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_bcc22c68ed1a6089966d8fec9e02cb2d.svg) | 2-Methyl-5-(7-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol | IC50 | 477000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_d360a09ca57adcb786c86bec24f1331f.svg) | 5-(5,6-Dimethyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-2-methyl-phenol | IC50 | 310000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_eae2e227a916dd12a9fcbc8efd912a0b.svg) | 3-Piperidin-1-ylpropyl N-[4-[2,4-difluoro-5-(methoxycarbamoyl)anilino]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate | IC50 | 62.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_dd8b84ce2497ba602024b6e988e9cccd.svg) | 5-[[6-[5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]-2,4-difluoro-N-methoxybenzamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_effbc8a9a0ffea45b0122c6893b03837.svg) | N-(4-Chlorophenyl)sulfonyl-4-(dimethylamino)benzamide | IC50 | 16000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_a83be1904b9ccca47bb4ec988b53a006.svg) | 2,4-Dichloro-N-(4-methoxyphenyl)sulfonylbenzamide | IC50 | 350.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_0cc1089d5cc9c1bde34acbece369318b.svg) | 2,4-Dichloro-N-(3-methoxyphenyl)sulfonylbenzamide | IC50 | 910.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6d8ebe2d6b402f2a6ea7442ab05ac5b5.svg) | 3-Chloro-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_4a43c162b79582df0d50a6b337c18683.svg) | 2,4-Dichloro-N-(3-chloro-4-fluorophenyl)sulfonylbenzamide | IC50 | 410.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_562ffb1486fdf3cb6d0d06fbce47ca02.svg) | 2,5-Dichloro-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_ab487a2c87307fb0f539d8cf49fa08aa.svg) | 4-Chloro-N-(4-chlorophenyl)sulfonyl-2-propylbenzamide | IC50 | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_bdb79ff856732809c11f1ad602d43f10.svg) | 2,4-Dibromo-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_2ac8bedc2a3d1feb0a4255d69dfe1a29.svg) | 4-Chloro-N-(4-chlorophenyl)sulfonyl-2-nitrobenzamide | IC50 | 5900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_b4ea068ae01f0e6404be92ac61d169ba.svg) | 2,4-Dichloro-N-(3,4-dimethoxyphenyl)sulfonylbenzamide | IC50 | 3900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_b168dc3c24069c20f9da2aed958c86da.svg) | 2,4-Dichloro-N-(3,5-dichlorophenyl)sulfonylbenzamide | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_348c1d7ef275ab10b445222883ca9b75.svg) | 4-Bromo-N-(4-chlorophenyl)sulfonyl-2-methylbenzamide | IC50 | 610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_2813ebc21f1955ce75effae6c546a362.svg) | N-(3-Bromophenyl)sulfonyl-2,4-dichlorobenzamide | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_1d0409dfa36be1ecffd387b0f0987794.svg) | N-(4-Acetylphenyl)sulfonyl-2,4-dichlorobenzamide | IC50 | 560.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_9e7630b5603a586105a5f09bd5c425ea.svg) | 2,4-Dichloro-N-[4-(dimethylamino)phenyl]sulfonylbenzamide | IC50 | 930.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_cf74ab59cb071e075e5d9221b09764a2.svg) | 2,4-Dichloro-N-(3-nitrophenyl)sulfonylbenzamide | IC50 | 910.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_a0e7083d06a974f22ab2952a99b30eb7.svg) | N-(4-Chlorophenyl)sulfonyl-2-nitro-4-(trifluoromethyl)benzamide | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_1d46b47436ca96a8f7a9f318aca2df60.svg) | N-(2-Methoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride | IC50 | 3260.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_87ff10c623f7889b6317b370d5019050.svg) | 4-Chloro-N-(4-chlorophenyl)sulfonyl-2-methoxybenzamide | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_c1f87afc683c03ea31c965ffc4b4ed80.svg) | 2-Chloro-N-(4-chlorophenyl)sulfonyl-4-nitrobenzamide | IC50 | 620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_68870af97c84be4b05f2fac6ec984e82.svg) | N-(3,4-Dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride | IC50 | 1130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_9e8386415b8619957958aa9977ce7091.svg) | 2,4-Dichloro-N-(4-methylphenyl)sulfonylbenzamide | IC50 | 210.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_600ef50a1f322460c5eabf9fb865e719.svg) | 2,4-Dichloro-N-(3-chlorophenyl)sulfonylbenzamide | IC50 | 440.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_93049dcbc23761d9c171367da02bee22.svg) | 3-Bromo-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_329b414123b39f622e5b8fa0db7493c9.svg) | 2,4-Dichloro-N-(3-chloro-4-methylphenyl)sulfonylbenzamide | IC50 | 360.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_b2a7fbc5882baa24493bbffc30ea97be.svg) | 2,4-Dichloro-N-(3,4-dibromophenyl)sulfonylbenzamide | IC50 | 910.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_bb841c5080e1a9cc4318812dce9658d5.svg) | 4-Chloro-N-(4-chlorophenyl)sulfonyl-2-ethylbenzamide | IC50 | 630.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_b9fcc05983b3afb2a27400a089bca71c.svg) | N-(4-Chlorophenyl)sulfonyl-2-methylbenzamide | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_3d9a4f7f7eec75fd895fee1208f1b68a.svg) | N-(4-Chlorophenyl)sulfonyl-2,4-dimethoxybenzamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_aea1d526116e036946d0a069fcf9c72f.svg) | N-(3-Chloro-4-fluorophenyl)-7-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine | IC50 | 2500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_f9dfc4705739072a1899cbb150f8d89f.svg) | N-(2-Bromo-4-methylphenyl)sulfonyl-2,4-dichlorobenzamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_cc01093be73fd869ca22917e71eb1e51.svg) | N-(4-Chlorophenyl)sulfonyl-2,4-dinitrobenzamide | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_64680361836be078eca3df8adc3fc04f.svg) | 2-Amino-4-chloro-N-(4-chlorophenyl)sulfonylbenzamide | IC50 | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_6e124cb4ee67ee36ccc17ebc026992e0.svg) | 2,4-Dichloro-N-(2-chlorophenyl)sulfonylbenzamide | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_56d0c92de914393ce412156a69fd2049.svg) | Ethyl N-[4-[2,4-difluoro-5-(methoxycarbamoyl)anilino]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate | IC50 | 31.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_e00b0dca352c7d4e62f6d248eb273d51.svg) | (1-Methylpiperidin-4-yl) N-[4-[2,4-difluoro-5-(methoxycarbamoyl)anilino]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate | IC50 | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor_45ebc01d896d4933bf41e3b80eae7073.svg) | 2,4-Difluoro-N-methoxy-5-[[6-(5-methyl-1H-1,2,4-triazol-3-yl)-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]benzamide | IC50 | 50.0 [1] |